Disposable Upstream Bioprocessing Technologies / Equipment Market, 2035 – ResearchAndMarkets.com

DUBLIN – (COMMERCIAL LINE) – The report “Disposable Upstream Bioprocessing Technology / Equipment by Product Type, Operational Scale and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” has been added to by ResearchAndMarkets.com offer.

The “Single Use Upstream Bioprocessing Equipment / Technologies Market” report presents an in-depth study of the current landscape and likely future potential of developers of single-use upstream bioprocessing technologies and equipment over the next 15 years. The study also presents an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.

One of the key objectives of the report was to understand key growth drivers and estimate the future size of the single-use upstream bioprocessing technologies / equipment market. Based on multiple parameters, such as the overall market for upstream bioprocessing equipment and the share of single-use technology, we have provided an informed estimate of market evolution for the period 2022-2035.

Over time, organic products have gained considerable popularity due to their therapeutic efficacy, favorable safety profiles and ability to treat a wide variety of disease indications that would otherwise be difficult to treat. The success of these interventions prompted interested parties to update the traditional production technology of organic products. The demand for higher productivity and flexibility, higher profitability and faster time to market are further driving the replacement of traditional stainless steel equipment with single-use technologies.

These technologies have been well accepted in a relatively shorter period of time and have become an important tool in the development of various biotechnological processes. Additionally, the ongoing COVID-19 pandemic has prompted the biopharmaceutical industry to switch to single-use technology. These technologies not only reduce footprint requirements, but also eliminate cleaning costs in the development phase.

Furthermore, single-use technologies have the potential to address a number of challenges associated with traditional bio-treatment systems and offer various additional benefits, such as reduced water and energy consumption (by approximately 45%), lower initial investment cost ( by 40%), shorter time to process organic products (by 33%), decreased risk of cross contamination (by 8%) and increased cost savings potential (by 30-40%).

The report features detailed transcripts of interviews held with the following industry players:

  • Christopher Brau (Research and development staff scientist and engineer, Thermo Fisher Scientific)

  • Nico Oosterhuis (Technical director and co-owner, Celltainer Biotech)

Answers to key questions

  • Who are the major players offering single-use upstream bioprocessing technologies?

  • What are the different application areas where single-use upstream bioprocessing technologies can be used?

  • In which regions are most of the single-use upstream bioprocessing technology providers located?

  • What is the relative competitiveness of the different single-use upstream bioprocessing technologies?

  • What are the main features of disposable bioreactors?

  • How has the intellectual property landscape of single-use upstream bioprocessing technologies evolved over the years?

  • What is the current supply and demand of organic product manufacturing through single-use upstream bioprocessing technology?

  • How are present and future opportunities likely to be distributed across key market segments?

Key topics covered:

1. FOREWORD

1.1. Overview

1.2. Scope of the report

1.3. Research methodology

1.4. Answers to key questions

1.5. Outlines of the chapter

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter overview

3.2. Overview of single-use upstream bioprocessing technology

3.3. Historical evolution of single-use upstream bioprocessing technology

3.4. Types of single-use upstream bioprocessing technology

3.5. Applications of single-use upstream bioprocessing technology

3.6. Main challenges associated with single-use upstream bioprocessing technology

3.7. Future perspective

4. MARKET LANDSCAPE: DISPOSABLE BIOREACTORS

4.1. Chapter overview

4.2. Disposable bioreactors: product list

4.3. Single-use bioreactors: developer landscape

5. MARKET LANDSCAPE: DISPOSABLE MIXERS

5.1. Chapter overview

5.2. Disposable mixers: List of products

5.3. Disposable mixer: developer landscape

6. MARKET LANDSCAPE: DISPOSABLE SENSORS

6.1. Chapter overview

6.2. Disposable Sensors: Product List

6.3. Disposable Sensors: Developer Landscape

7. MARKET LANDSCAPE: OTHER DISPOSABLE BIOPROCESS TECHNOLOGIES UP UPSTREAM

7.1. Chapter overview

7.2. Bags and containers for disposable supports

7.3. Disposable filters

7.4. Disposable Sampling Systems

7.5. Disposable connectors

8. ANALYSIS OF THE COMPETITIVENESS OF THE PRODUCT

8.1. Chapter overview

8.2. Methodology

8.3. Assumptions / key parameters

8.4. Competitiveness analysis of the product: disposable bioreactors

8.5. Competitiveness analysis of the product: disposable mixers

8.6. Product competitiveness analysis: disposable sensors

9. SUPPLIERS OF DISPOSABLE UPSTREAM BIOPROCESSING TECHNOLOGIES IN NORTH AMERICA: COMPANY PROFILES

9.1. Chapter overview

9.2. Avant

9.3. Citiva

9.4. Merck KGaA

9.5. Ball

9.6. Thermo Fisher Scientific

10. SUPPLIERS OF UPSTREAM DISPOSABLE BIOPROCESSING TECHNOLOGY IN EUROPE: COMPANY PROFILES

10.1. Chapter overview

10.2. Eppendorf

10.3. Saint-Gobain

10.4. Sartorio

11. SUPPLIERS OF UPSTREAM DISPOSABLE BIOPROCESSING TECHNOLOGIES IN ASIA-PACIFIC: COMPANY PROFILES

11.1. Chapter overview

11.2. Satake Multimix

11.3. CHALLENGE

11.4. Prema Biotechnology

12. PATENT ANALYSIS

12.1. Chapter overview

12.2. Scope and methodology

12.3. Disposable Upstream Bioprocessing Technology: Patent Analysis

12.4. Comparative analysis of patents

13. MARK POSITIONING MATRIX

13.1. Chapter overview

13.2 Methodology

13.3. Key parameters

13.4. Brand positioning matrix of single-use bioreactor developers

13.4.1. Brand positioning matrix: Pall Corporation

13.4.2. Brand positioning matrix: Eppendorf

13.4.3. Brand positioning matrix: Solaris Biotech

13.4.4. Brand positioning matrix: Sartorius Stedim Biotech

13.4.5. Brand positioning matrix: Applikon Biotechnology

13.4.6. Brand positioning matrix: CerCell

13.4.7. Brand positioning matrix: Synthecon

13.5. Brand positioning matrix of single-use mixer developers

13.5.1. Brand Positioning Matrix: Thermo Fisher Scientific

13.5.2. Brand positioning matrix: Merck Millipore

13.5.3. Brand positioning matrix: Cytiva Lifesciences

13.5.4. Brand positioning matrix: Pall Corporation

13.6. Brand positioning matrix from single-use sensor developers

13.6.1. Brand positioning matrix: Masterflex

13.6.2. Brand positioning matrix: Levitronix

13.6.3. Brand positioning matrix: Malema Engineering

13.6.4. Brand positioning matrix: Parken Hannifin

13.6.5. Brand positioning matrix: Pendo TECH

14. CASE STUDY: COST AND TIME SAVING POTENTIAL OF UPSTREAM DISPOSABLE BIOPROCESSING TECHNOLOGY

14.1. Chapter overview

14.2. Overall cost saving potential of upstream disposable biotreatment technology, 2022-2035

14.2.1. scenario 1

14.2.1.1. Key assumptions and methodology

14.2.1.2. Cost savings potential with the acquisition of single-use upstream technology, 2022-2035

14.2.2. Scenario 2

14.2.2.1. Key assumptions and methodology

14.2.2.2. Cost savings potential with the implementation of single-use upstream bioprocessing technology, 2022-2035

14.3. Overall time saving potential of upstream disposable biotreatment technology, 2022-2035

14.4. Concluding remarks

15. ANALYSIS OF THE DEMAND AND THE OFFER

15.1. Chapter overview

15.2. Key assumptions and methodology

15.3. Global demand for organic products, 2022-2035

15.4. Concluding remarks

16. MARKET FORECAST AND OPPORTUNITY ANALYSIS

16.1. Chapter overview

16.2. Forecasting methodology and key hypotheses

16.3. Disposable Upstream Bioprocessing Technology Global Market, 2022-2035

17. CONCLUSION

17.1. Chapter overview

18. EXECUTIVE INSIGHTS

18.1. Chapter overview

18.2. Celltainer Biotech

18.2.1. Company snapshot

18.2.2. Transcript of the interview: Nico Oosterhuis, Technical director and co-owner

18.3. Thermo Fisher Scientific

18.3.1. Company snapshot

18.3.2. Transcript of the interview: Christopher Brau, research and development staff scientist and engineer

19. APPENDIX 1: TABLE DATA

20. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information on this report, please visit https://www.researchandmarkets.com/r/8asrgo

Leave a Comment

Your email address will not be published.